Michael Myers
Chief Executive Officer chez QUOIN PHARMACEUTICALS, LTD.
Fortune : 8 890 $ au 31/03/2024
Profil
Michael Myers is the founder and currently holds the position of Chairman & Chief Executive Officer at Quoin Pharmaceuticals Ltd., which was founded in 2018.
He is also currently serving as President & Chief Executive Officer at Innocoll Pharmaceuticals Ltd., Innocoll Technologies Ltd., Chief Executive Officer & Director at Quoin Pharmaceuticals, Inc., Director at Wellesley Pharmaceuticals LLC, Director at Sonoran Biosciences, Inc., and Independent Director at SquareX Pharmaceuticals Corp.
Additionally, Dr. Myers has held former positions as President, Chief Executive Officer & Director at Innocoll Holdings, Inc., President, Chief Executive Officer & Director at Innocoll, Inc., President & Chief Executive Officer at Innocoll AG, President-Pharmaceutical Operations at Fuisz Technologies Ltd., President-Drug Delivery Division at West Pharmaceutical Services, Inc., Chief Commercial Officer & Executive VP at Avadel Pharmaceuticals Plc, and Head-Pharmaceutical Development at Elan Corp.
Plc.
He obtained a doctorate degree from University College Cork.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/03/2024 | 9 358 ( 0,25% ) | 8 890 $ | 31/03/2024 |
Postes actifs de Michael Myers
| Sociétés | Poste | Début |
|---|---|---|
| QUOIN PHARMACEUTICALS, LTD. | Chief Executive Officer | 28/10/2021 |
Innocoll Pharmaceuticals Ltd.
 Innocoll Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Innocoll Pharmaceuticals Ltd. engages in pharmaceutical preparations. The company was founded on June 1, 2005 and is headquartered in Dublin, Ireland. | Chief Executive Officer | - |
Innocoll Technologies Ltd.
 Innocoll Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Innocoll Holdings Plc, Innocoll Technologies Ltd. is an Irish company located in Athlone that engages in research and experimental development on natural sciences and engineering. Michael Myers is the current CEO of the firm. | Chief Executive Officer | - |
Wellesley Pharmaceuticals LLC
 Wellesley Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA. | Director/Board Member | - |
| Sonoran Biosciences, Inc. | Director/Board Member | - |
Quoin Pharmaceuticals, Inc.
 Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | Chief Executive Officer | - |
SquareX Pharmaceuticals Corp.
 SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Director/Board Member | 01/11/2022 |
Anciens postes connus de Michael Myers
| Sociétés | Poste | Fin |
|---|---|---|
Innocoll, Inc.
 Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Chief Executive Officer | 01/01/2015 |
| AVADEL PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/01/2001 |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Formation de Michael Myers
| University College Cork | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Health Technology |
| AVADEL PHARMACEUTICALS PLC | Health Technology |
| QUOIN PHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Fuisz Technologies Ltd.
 Fuisz Technologies Ltd. Pharmaceuticals: MajorHealth Technology Part of Bausch Health Cos., Inc., Fuisz Technologies Ltd. is a private company that develops and commercializes rapid dissolving tablets for over-the-counter and prescription pharmaceuticals. The company is based in Chantilly, VA. Fuisz Technologies was acquired by Biovail Corp. on November 12, 1999 for $145.48 million. | Health Technology |
Innocoll Holdings, Inc.
 Innocoll Holdings, Inc. Pharmaceuticals: MajorHealth Technology Innocoll Holdings, Inc. manufactures pharmaceutical products. The company is based in Ashburn, VA. | Health Technology |
Wellesley Pharmaceuticals LLC
Wellesley Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wellesley Pharmaceuticals LLC develops and markets drugs for treating Nocturia. The company was founded by David A. Dill in 2011 and is headquartered in Newtown, PA. | Health Technology |
Innocoll, Inc.
Innocoll, Inc. Pharmaceuticals: MajorHealth Technology Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA. | Health Technology |
Innocoll Pharmaceuticals Ltd.
Innocoll Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Innocoll Pharmaceuticals Ltd. engages in pharmaceutical preparations. The company was founded on June 1, 2005 and is headquartered in Dublin, Ireland. | Health Technology |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Innocoll Technologies Ltd.
Innocoll Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Innocoll Holdings Plc, Innocoll Technologies Ltd. is an Irish company located in Athlone that engages in research and experimental development on natural sciences and engineering. Michael Myers is the current CEO of the firm. | Commercial Services |
| Sonoran Biosciences, Inc. | |
Quoin Pharmaceuticals, Inc.
Quoin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quoin Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Las Vegas, NV. | Health Technology |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Health Technology |
